
Strategies for Transformational Growth
We help life science companies uncover market opportunities, navigate complexity, and accelerate commercial success.
get startedinteract to explore
Product Evolution
Market Intelligence
Investment Readiness
Portfolio Strategy
We Tackle Critical Business Questions
SWIPE TO EXPLORE
Product Evolution
- What does the product need to do to compete?
- What is the market sentiment for my product?
- Will it address key market requirements?
- What is the optimal pricing strategy?
- How will the reimbursement landscape evolve?
- What’s the best regulatory path?
- What is the best go-to-market approach?
Market Intelligence
- What’s the true revenue potential for my product?
- What is the size and segmentation of the market?
- Does the model reflect changing market and competitive dynamics?
- What requirements are critical for entry?
- How will the technology landscape evolve?
- Under what assumptions do today’s unmet needs persist?
Investment Readiness
FOR INVESTORS
- What are the characteristics of the optimal targets?
- Does it do what it claims?
- Is it significantly better than the status quo?
- How much work is left?
FOR FOUNDERS
- How do I maximize our valuation?
- When am I ready for a raise?
- How I demonstrate progress?
- How do I position my company to investors?
Portfolio Strategy
- Should we build, buy, or partner?
- When should we enter the market?
- What are the best verticals for investment?
- Where are the gaps in our existing portfolio?
- What R&D projects should we advance or sunset?
- How do I excite my organization around a new class of solution?

A History of Transformation
Our clients and their challenges are global. We tackle some of the industry’s toughest scientific and commercial challenges across a broad set of markets and technologies. From pre-funding startups to multinational corporations, the most ambitious teams trust Chrysalis to shape their strategy.
70+
Companies Served
10+
Years of Life Science Strategy
Why We're Different
Industry
Veterans
We've walked in the shoes of our customers, entering new markets and launching industry-changing products. We harness the learnings from decades of successes and failures, bringing clients the confidence to make difficult, high-stakes decisions.
Insiders with
Relationships
Our decades-long relationships with leading scientists, clinicians, and industry executives are personal and collegial, allowing Chrysalis to tap into unfiltered industry knowledge that other firms simply can't.
Actionable
Strategy
We understand the gap between theory and practice. As veteran advisors, we turn complex technology and market insights into best-practices, execution plans, and outcomes-driven strategies.
Hands-On
Approach
We don’t just advise. The founding Chrysalis partners collaborate, build, and roll up our sleeves to drive results with you.
Market Breadth
We help clients navigate healthcare innovation and unlock growth across diagnostics, therapeutics, and digital health.
interact below to explore
Placeholder Title
Click a hexagon... placeholder text
How We Work with Clients
Our principals stay involved from planning to execution — guiding the process, collaborating closely, and cutting through complexity.
Market Landscape
We define the opportunity: market, competitive, clinical, and customer context — analyzing unmet needs, adjacent spaces, and where innovation fits.
Opportunity Prioritization
We articulate the winning solution, quantify, and prioritize opportunities using market evidence, value drivers, and technical fit.
Strategic Pathways
We draw up the plan: develop tailored strategies aligned to your product, team, and business stage — from product-market fit to scale readiness.
Commercial Roadmap
We build actionable go-to-market plans — defining pricing, messaging, partnerships, and launch sequencing.
Activation & Execution
We identify immediate next steps for the project stakeholders and the organization to move the organization from planning and deliberation to execution and transformation.
Perspective from Our Clients
See how our work has supported commercialization, investment readiness, and product evolution.